IBS C News and Research

RSS
New therapy under development for the treatment of irritable bowel syndrome

New therapy under development for the treatment of irritable bowel syndrome

Many factors influence quality of life for patients with irritable bowel syndrome

Many factors influence quality of life for patients with irritable bowel syndrome

New drug application for cilansetron, an investigational product for the treatment of irritable bowel syndrome

New drug application for cilansetron, an investigational product for the treatment of irritable bowel syndrome

New risk factors associated with inflammatory bowel disease

New risk factors associated with inflammatory bowel disease

Mothers who are concerned about their own health may unwittingly be passing their anxieties on to their children

Mothers who are concerned about their own health may unwittingly be passing their anxieties on to their children

Significant symptom relief reported in clinical trial patients with irritable bowel syndrome

Significant symptom relief reported in clinical trial patients with irritable bowel syndrome

Researchers receive almost £1 million in funding for Irritable Bowel Syndrome

Researchers receive almost £1 million in funding for Irritable Bowel Syndrome

FDA updates Zelnorm labeling a treatment of women with irritable bowel syndrome

FDA updates Zelnorm labeling a treatment of women with irritable bowel syndrome

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.